CASSAVA SCIENCES INC Logo

CASSAVA SCIENCES INC

Clinical-stage biotech developing treatments for Central Nervous System disorders.

SAVA | US

Overview

Corporate Details

ISIN(s):
US69562K5065 (+1 more)
LEI:
Country:
United States of America
Address:
6801 N CAPITAL OF TEXAS HIGHWAY, 78731 AUSTIN

Description

Cassava Sciences, Inc. is a clinical-stage biotechnology company that develops investigational treatments for Central Nervous System (CNS) disorders. The company's primary focus is on its lead drug candidate, simufilam, a proprietary oral small molecule. Simufilam is designed to modulate the activity of the filamin A (FLNA) protein, which is involved in regulating neuronal development. The development program for simufilam targets conditions such as tuberous sclerosis complex (TSC)-related epilepsy and other mTOR pathway disorders. Preclinical studies in TSC models have shown that simufilam may reduce seizure frequency, supporting plans for future clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-23 14:46
FORM 8-K
English ZIP 59.9 KB
2025-12-22 22:09
FORM 8-K/A
English ZIP 57.8 KB
2025-12-18 23:02
FORM 8-K
English ZIP 56.9 KB
2025-12-17 22:12
FORM 8-K
English ZIP 57.3 KB
2025-12-08 06:15 English ZIP 5.2 KB
2025-12-05 22:49
424B2
English ZIP 165.0 KB
2025-12-03 12:27
FORM 8-K
English ZIP 57.0 KB
2025-11-25 22:06
FORM 4
English ZIP 6.4 KB
2025-11-24 22:02
FORM 4
English ZIP 7.1 KB
2025-11-20 23:39
FORM 4
English ZIP 7.2 KB
2025-11-13 03:59
S-3
English ZIP 400.8 KB
2025-11-12 22:02
FORM 10-Q
English ZIP 1.0 MB
2025-11-12 14:10
FORM 8-K
English ZIP 102.5 KB
2025-10-24 14:10
FORM 8-K
English ZIP 56.9 KB
2025-10-23 00:15
FORM 4
English ZIP 6.9 KB

Automate Your Workflow. Get a real-time feed of all CASSAVA SCIENCES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CASSAVA SCIENCES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CASSAVA SCIENCES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.